Global DNA-Encoded Library (DEL) Technology Market Growth (Status and Outlook) 2024-2030

Global DNA-Encoded Library (DEL) Technology Market Growth (Status and Outlook) 2024-2030

The principle of DNA Encoded Library (DEL) technology is to label each small molecule compound in the reaction process with a small specific DNA sequence, and use the "Split and Pool" strategy of combinatorial chemistry to synthesize compound libraries with DNA sequences of millions or even billions in size. Affinity screening was performed between the DNA coding compound library and the target protein. Compounds that did not effectively bind to the target protein were eluted and removed, resulting in a collection of compounds that can bind to the protein. The DNA sequences of these compounds were amplified and amplified using Polymerase, and then detected by second-generation gene sequencing. Because the DNA sequences correspond one-to-one with small molecule compounds, researchers only need to read the DNA sequences on the molecules that bind to the target protein to decode the molecular structural formula that binds to the target protein.

The global DNA-Encoded Library (DEL) Technology market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “DNA-Encoded Library (DEL) Technology Industry Forecast” looks at past sales and reviews total world DNA-Encoded Library (DEL) Technology sales in 2022, providing a comprehensive analysis by region and market sector of projected DNA-Encoded Library (DEL) Technology sales for 2023 through 2029. With DNA-Encoded Library (DEL) Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA-Encoded Library (DEL) Technology industry.

This Insight Report provides a comprehensive analysis of the global DNA-Encoded Library (DEL) Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on DNA-Encoded Library (DEL) Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA-Encoded Library (DEL) Technology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA-Encoded Library (DEL) Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA-Encoded Library (DEL) Technology.

United States market for DNA-Encoded Library (DEL) Technology is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for DNA-Encoded Library (DEL) Technology is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for DNA-Encoded Library (DEL) Technology is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key DNA-Encoded Library (DEL) Technology players cover HitGen, X-Chem, Amgen(Nuevolution), Vipergen, WuXi AppTec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of DNA-Encoded Library (DEL) Technology market by product type, application, key players and key regions and countries.

Segmentation by Type:
Screening Service
DNA-encoded Library Customized Service
Other

Segmentation by Application:
Pharmaceutical Company
Biotechnology Company
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Screening Service
DNA-encoded Library Customized Service
Other

Segmentation by Application:
Pharmaceutical Company
Biotechnology Company
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
HitGen
X-Chem
Amgen(Nuevolution)
Vipergen
WuXi AppTec
Philochem
DICE THERAPEUTICS
HotSpot Therapeutics(Macroceutics)
Dynabind

Please note: The report will take approximately 2 business days to prepare and deliver.